UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 

 

Date of Report (Date of Earliest Event Reported): July 2, 2003

 

 

ADVANCED MAGNETICS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware

 

Commission File No. 0-14732

 

04-2742593

(State or other jurisdiction
of incorporation)

 

 

 

(I.R.S. Employer
Identification No.)

 

 

 

 

 

61 Mooney Street
Cambridge, Massachusetts

 

 

 

02138

(Address of principal executive offices)

 

 

 

(Zip Code)

 

 

 

Registrant’s telephone number, including area code: (617) 497-2070

 

 

 

Item 5.  Other Events.

 

On June 18, 2003, Advanced Magnetics, Inc. announced the publication of clinical data in the New England Journal of Medicine showing that magnetic resonance imaging with Combidex®, the Company’s investigational iron oxide nanoparticle used to aid in the diagnosis of lymph node disease, allows for the noninvasive assessment of lymph nodes in patients with prostate cancer.  A copy of the press release is attached hereto as Exhibit 99.1.

 

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

ADVANCED MAGNETICS, INC.

 

 

 
 
By:
/s/ Jerome Goldstein

 

Name:

Jerome Goldstein

 

Title:

Chief Executive Officer, President,
Treasurer and Chairman of the Board
of Directors

Dated:  July 2, 2003

 

 

 

 

3